The SMA condition manifests in humans due to the presence of a near identical gene, SMN2, that could potentially encode a normal SMN but which is inappropriate for splicing of the majority of SMN2 transcripts, and hence, low expression of the full-length SMN (FL-SMN). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.